Northern Financial Advisors’s AbbVie ABBV Stock Holding History

Northern Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$934K	Sell	3,712 -63	-2%	-$13.6K	0.62%	48
2026 Q1	$821K	Buy	3,775 +1,352	+56%	+$300K	0.6%	54
2025 Q4	$554K	Sell	2,423 -1,500	-38%	-$342K	0.63%	48
2025 Q3	$908K	Sell	3,923 -46	-1%	-$9.37K	0.48%	57
2025 Q2	$737K	Buy	3,969 +563	+17%	+$105K	0.55%	52
2025 Q1	$714K	Sell	3,406 -51	-1%	-$9.91K	0.59%	55
2024 Q4	$614K	Sell	3,457 -101	-3%	-$18.6K	0.49%	59
2024 Q3	$703K	Sell	3,558 -17	-0.5%	-$3.17K	0.53%	60
2024 Q2	$613K	Hold	3,575	–	–	0.49%	64
2024 Q1	$651K	Sell	3,575 -20	-0.6%	-$3.45K	0.51%	67
2023 Q4	$557K	Sell	3,595 -944	-21%	-$138K	0.47%	67
2023 Q3	$677K	Buy	4,539 +662	+17%	+$97.2K	0.62%	51
2023 Q2	$522K	Sell	3,877 -787	-17%	-$115K	0.46%	67
2023 Q1	$743K	Buy	+4,664	New	+$713K	0.7%	47

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Financial Advisors's ABBV Position: Q2 2026 in Review

Northern Financial Advisors reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $13.6K and leaving 3,712 shares worth $934K. The position accounts for 0.62% of the portfolio, ranked #48.

Northern Financial Advisors first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Northern Financial Advisors held 3,712 shares of AbbVie worth $934K as of Q2 2026.
Northern Financial Advisors sold 63 AbbVie shares in Q2 2026, an estimated $13.6K.
AbbVie made up 0.62% of Northern Financial Advisors's portfolio in Q2 2026, its #48 holding.
Northern Financial Advisors first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Northern Financial Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.